Insecticides (India) Reports Q2 & H1 FY27 Results With Robust Product Portfolio
Insecticides (India) Ltd · Investor Presentation · 05 Nov 2026, 9:43 pm
Insecticides (India) Reports Q2 & H1 FY27 Results With Robust Product Portfolio Insecticides (India) reported consolidated Q2FY27 revenue of ₹686.31 crore (+8% YoY), EBITDA of ₹92.44 crore (+3% YoY, 13.5% margin), and PAT of ₹56.17 crore (-5% YoY). For H1FY27, revenue stood at ₹1,297.84 crore (-2% YoY) with PAT at ₹100.04 crore (-15% YoY). The company expanded premium products to 58% of B2C revenue by FY26. B2C sales mix comprises 49% insecticides, 37% herbicides, 10% fungicides, and 4% biologicals/PGR. Growth strategies focus on R&D collaborations with Corteva and Nissan Chemical, brand expansion via KAEROS, and scaling exports across 22 countries.
Original exchange filing (PDF)
More announcements from Insecticides (India) Ltd
- Earnings Call Transcript for quarter and half year ended September 30, 2026 · 12 Nov 2026
- Press Release For Q2 & H1 Of FY 2026-27 Results. · 05 Nov 2026
- Insecticides (India) Limited has informed the Exchange regarding Outcome of Board Meeting held on November 05, 2026. · 05 Nov 2026
- Press Release for Q2 & H1 of FY 2026-27 Results · 05 Nov 2026
- Appointment of Mr. Veera Bhadram Garimella as Independent Director (Additional) · 05 Nov 2026
- Appointment of Mr. Kapil Sharma as AVP- Tech. Services Projects and Manufacturing Excellence, a Senior Management Personnel (SMP) of the Company w.e.f November 05, 2026. · 05 Nov 2026
- Declaration of Dividend for FY 2026-2027 · 05 Nov 2026
- Declaration of Interim Dividend for FY 2026-27 · 05 Nov 2026
